Royal Bank Of Canada Graybug Vision, Inc. Transaction History

Royal Bank Of Canada

  • $471 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$0.76 - $1.25 $760 - $1,250
-1,000 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$3.18 - $5.17 $1,481 - $2,409
-466 Reduced 31.79%
1,000 $3,000
Q2 2021

Aug 16, 2021
BUY
$3.53 - $6.1 $5,174 - $8,942
1,466 New
1,466 $8,000

Others Institutions Holding GRAY

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About GRAYBUG VISION, INC.

GRAY Quotes by TradingView
  • Ticker GRAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 21,517,700
  • Market Cap $63.5M
  • Description
  • Graybug Vision, Inc., a clinical-stage biopharmaceutical company, focuses on the development of medicines for the treatment of diseases of the retina and optic nerve. The company's lead product candidate is GB-102, an intravitreal injection of a microparticle depot formulation of sunitinib that is in Phase I/IIa and IIb clinical trials for the t...
More about GRAY
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email